MARATTO

article · AJOB Empirical Bioethics

Is It a Bribe? Research Personnels’ Perceptions of the Ethical Aspects of Financial Compensation to Healthy Volunteers in Prevention Trials in Tanzania

In plain language

This study examined how clinical research staff in Tanzania view the ethics of offering financial payments to healthy volunteers in prevention trials. Semi-structured interviews were conducted with 36 research staff across six trials, including principal investigators, physicians, and support workers. The findings revealed that most personnel view financial compensation as an ethical obligation to respect volunteers' time and effort, particularly for participants facing barriers to joining trials, rather than as a bribe. However, some staff voiced concerns regarding the potential to inappropriately influence low-income individuals or create misconceptions about trial activities. Participants noted that both excessively high and overly low payments raise ethical problems, whereas modest amounts are considered fair. Consequently, updating national ethical guidelines to clearly define fair compensation could provide clearer local guidance while protecting volunteers.

Key takeaways

  • Most research personnel view financial compensation for healthy volunteers as a respectful ethical duty rather than a bribe.
  • Concerns exist that financial payments might inappropriately influence low-income earners or foster misperceptions of research procedures.
  • Compensation levels that are either too high or too low were considered unethical, with modest rates viewed as appropriate.
  • National research guidelines require re-evaluation to clearly define fair and just compensation standards for clinical trial participants.

Why it matters

Determining how to ethically compensate clinical trial participants is critical for fair medical research. If payments are too low, participants are unfairly burdened; if payments are too high, they risk unduly influencing people. Clarifying these boundaries ensures that vulnerable populations are treated with dignity, study recruitment remains ethical, and clinical research operates under transparent, trustworthy standards.

Commercialisation angle

The findings can inform clinical trial operations, contract research organisations, and policy makers updating clinical governance frameworks in Tanzania. Clearer guidelines could streamline recruitment and trial management for commercial and academic sponsors, though the research itself is policy-focused and does not present a direct commercial product.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

BACKGROUND: Financial compensation may be perceived as a catalyst to increase the recruitment and retention of healthy volunteers in clinical trials but also potentially as a form of undue inducement. The ethical guidelines in Tanzania, while helpful, are not clear on what is considered reasonable compensation for healthy volunteers and the extent to which it influences participation. This study aimed to explore research personnels' perceptions of the ethical aspects of financial compensation to healthy volunteers participating in prevention trials in Tanzania. METHODS: Qualitative semi-structured interviews were conducted in Tanzania with a purposive sample of 36 research personnel with different project roles ranging from principal investigators (PIs) to study staff on six prevention trials. The interviews were recorded and transcribed verbatim and thematic analysis was performed. RESULTS: Most research personnel were physicians (64%) and male (67%) with a mean age of 48 years. Three qualitative themes were identified: ethical justifications for financial compensation, ethical concerns about financial compensation and fair compensation as income. Most Tanzanian research personnel were more aligned with the view that financial compensation is an ethical responsibility in respecting the value of a healthy volunteer's time and effort, especially for those who face barriers to participation, rather than being a bribe. However, there were those who raised ethical concerns about financial compensation that included perceptions of bribing low-income earners and increased misperceptions of trial activities. Research personnel also indicated that the specific amount of financial compensation has ethical implications. Amounts that were either too much or too little were viewed as unethical, whereas a modest rate was perceived as ethical. CONCLUSIONS: Paying healthy volunteers is a measure of respect and supported by the national Tanzanian research guidelines. However, a reevaluation of these research ethical guidelines to redefine reasonable, fair and just financial compensation, especially for those who face significant barriers to participation, would continue to respect healthy volunteers and provide regional guidance for researchers within the country.

Research topics

  • Ethics in Clinical Research
  • Global Health and Surgery
  • Mental Health and Patient Involvement

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/23294515.2025.2474910

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.